Rani Therapeutics Inc. (RANI)

NASDAQ: RANI · Real-Time Price · USD

1.09

0.02 (1.87%)

At close: May 02, 2025, 3:59 PM

1.10

0.83%

After-hours: May 02, 2025, 04:36 PM EDT

Rani Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-56.58M	-33.97M	-63.34M	-53.09M	-16.7M	-26.59M
Depreciation & Amortization	1.03M	822K	548K	497K	589K	564K
Stock-Based Compensation	16.03M	19.01M	15.78M	22.59M	n/a	n/a
Other Working Capital	-827K	-1.54M	346K	-3.97M	111K	108K
Other Non-Cash Items	4.03M	-34.96M	-10K	109K	110K	-81K
Deferred Income Tax	n/a	n/a	n/a	1.07M	n/a	n/a
Change in Working Capital	n/a	-2.14M	509K	-3.43M	1.04M	-163K
Operating Cash Flow	-35.5M	-51.24M	-46.52M	-32.24M	-14.96M	-26.27M
Capital Expenditures	-268K	-1.23M	-1.62M	-506K	-1.2M	-1.58M
Cash Acquisitions	n/a	n/a	-851K	n/a	n/a	49K
Purchase of Investments	-58.72M	-73.26M	-73.82M	n/a	n/a	n/a
Sales Maturities Of Investments	77.55M	104.35M	3M	n/a	n/a	n/a
Other Investing Acitivies	1.25M	n/a	851K	n/a	n/a	49.00
Investing Cash Flow	19.81M	29.86M	-72.44M	-506K	-1.2M	-1.53M
Debt Repayment	-5M	n/a	29.57M	-2.85M	4.19M	n/a
Common Stock Repurchased	304K	-162	-626	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	323K	233K	-569K	79.99M	n/a	852K
Financial Cash Flow	13.59M	233K	29M	77.15M	72.68M	852K
Net Cash Flow	-2.1M	-21.14M	-89.95M	44.4M	56.52M	-26.95M
Free Cash Flow	-35.76M	-52.47M	-48.13M	-32.75M	-16.16M	-27.85M